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ABSTRACT
Objective The objective of this study was to externally
validate a clinical prediction rule (CPR)—the ‘Shapiro
criteria’—to predict bacteraemia in an acute medical
unit (AMU).
Methods Prospectively collected data, retrospectively
evaluated over 11 months in an AMU in the UK. From
4810 admissions, 635 patients (13%) had blood
cultures (BCs) performed. The 100 cases of true
bacteraemia were compared with a randomly selected
sample of 100 control cases where BCs were sterile.
Results To predict bacteraemia (at a cut-off score of
two points), the Shapiro criteria had a sensitivity of 97%
(95% CIs 91% to 99%), speciﬁcity 37% (28% to 47%),
positive likelihood ratio 1.54 (1.3 to 1.8) and a negative
likelihood ratio of 0.08 (0.03 to 0.25). The area under
the receiver operating curve was 0.80 (0.74 to 0.86),
and the Hosmer–Lemeshow p value was 0.45.
Conclusions A score ≥2 on the Shapiro criteria had
high sensitivity in a study of acute general medical
admissions. Application of the rule in patients being
considered for a BC could identify those at low risk of
bacteraemia. Though the model demonstrated good
discrimination, the lengthy number of variables (13)
and difﬁculty automating the CPR may limit its use.
Q6
Q7
INTRODUCTION
Early detection of bacteraemia is of indisputable
clinical importance, indicating disseminated infec-
tion, which is associated with a worse prognosis
than that for patients with local infection.1 The sys-
temic inﬂammatory response syndrome (SIRS) cri-
teria2 are of limited use in differentiating a patient
with and without infection.3–5 A fever commonly
prompts a blood culture (BC), yet ,13%–24% of
patients with signiﬁcant bacteraemia are normother-
mic,5–7 and in one study, over half the patients
admitted to an intensive care unit (ICU) with sepsis
were normothermic.8 BC results take at least 24 h to
be known, and false-positive or false-negative results
are common. This has implications for antimicrobial
stewardship, and patients may undergo unnecessary
treatment and investigations.9–13 Positive yields are
remarkably low (4%–8%), reﬂecting the lack of
well-deﬁned indications to take a BC.3 14–16
Prompt initiation of appropriate antimicrobial
therapy improves outcomes in patients with severe
sepsis, yet is commonly absent, suggesting diagnosis
in some patients is challenging.17–20 Senior cliniciansQ9
may be more accurate at predicting risk of death
compared with available clinical scoring systems.21
However, it is junior clinicians who often make the
decision to draw a BC and initiate antibiotics, and
there is evidence that this group both overestimate
and underestimate the probability of bacter-
aemia.22 23 Challenges in diagnosis, investigation
and management of patients with signiﬁcant infec-
tions have led to the development of a number of
clinical prediction rules (CPRs) to help predict
bacteraemia.24 Few have been externally validated,
and where this has occurred, performance has
been inferior.25 None have undergone an impact
analysis—unfortunately true of most CPRs in the
medical literature.26 One CPR with major and minor
criteria27—the ‘Shapiro criteria’ (see table 1)—has
been shown to be a sensitive but not speciﬁc pre-
dictor, and was recently validated in an emergency
department (ED) setting.28 The objective of this
study was to provide further external validation of
the Shapiro criteria in an acute medical unit (AMU)
population. The TRIPOD checklist29 for the study
can be seen in online supplementary appendix 1.
METHODS
Design
Single-centre nested case–control study with pro-
spectively collected data, retrospectively analysed.
Key messages
What is already known on this subject?
▸ Bacteraemia is clinically relevant, but often
difﬁcult to predict, while indiscriminate drawing
of blood cultures (BC) can negatively impact on
the management of patients.
▸ A Clinical prediction rule (the Shapiro criteria)
has been proposed to help guide when to
perform a BC, in particular by identifying those
patients with a suspected infection, but who
are at very low risk of bacteraemia.
▸ Our study looked to externally validate the
Shapiro criteria in a UK general medical cohort
of patients.
What might this study add?
▸ The Shapiro criteria has good discrimination to
predict bacteraemia when applied to a general
medical cohort in the UK.
▸ Its low speciﬁcity and use of a large number of
(sometimes subjective) variables may limit its
clinical application and more parsimonious
models should be investigated.
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The study proposal was internally peer reviewed, and a favour-
able ethical opinion was given from the NHS NRESQ10 Committee
London South-East (REC reference 13/LO/0884). The Research
and Governance Department of the Trust approved and pro-
vided research governance for the study. The consent of partici-
pants was deemed unnecessary due to the study design;
anonymised data analysis without clinical intervention.
Setting
The AMU on one site of an 870-bed hospital in the UK. Across
the two sites, the combined annual ED attendance is >75 000,
with 35–40 acute medical admissions per 24 h period. There is
a separate admissions unit for frail elderly patients. Patients are
admitted through the ED or directly from the local primary
care physicians or outpatients.
Subjects
Consecutive patients over an 11-month period (March 2012–end
January 2013), age ≥18 years who stayed at least one night in
hospital on the AMU were included in the provisional data col-
lection and followed up until discharge from hospital. No patient
was included on more than one occasion. Exclusion criteria
included patients <18 years, staying less than one night in hos-
pital or admitted to non-medical wards. All patients had physio-
logical observations measured and entered as part of standard
clinical practice via handheld systems into the hospitals clinical
data software system (Patientrack) by nursing staff with no input
from the research team. Baseline characteristics, demographic
data and blood results were obtained at the time of enrolment.
During the 11-month study period from 4810 patient episodes,
635 BCs were drawn (13%) within 24 h of admission. One
hundred and four (17%) were judged to represent true bacter-
aemia, having excluded 50 (7.9%) cultures deemed to be con-
taminants (37 of which were coagulase-negative Staphylococcus
species) using published criteria,30 31 and the opinion of the clin-
ical team and consultant microbiologist (independent of the
study team). Four patients were excluded as the relevant patient
data were unavailable, leaving 100 patients with bacteraemia in
the analysis to be compared with 100 patients, randomly selected
(using Excel) from the sterile-BC cohort (of 531 patients). The
research team had no inﬂuence on the care delivered to the
patients who received routine standard medical care.
Outcome measures
Patients with cultures were identiﬁed from the microbiology
department database. A positive BC result (reported by a
consultant microbiologist according to the result at 5 days) was
deﬁned as growth of bacteria with recognised pathogenic cap-
acity in ≥1 BC or a growth of a common skin pathogen in ≥2
BCs in the presence of SIRS and/or clinical evidence or micro-
biological ﬁndings suggesting a primary focus of infection—a
decision made jointly by the microbiology consultant and clin-
ical team looking after the patient with no inﬂuence from the
research team.30 31
Data included the relevant variables and independent predic-
tors of bacteraemia as noted by Shapiro et al27 apart from the
‘bands >5%’ variable, as this is not a routine test performed at
the Trust (see table 1). Band cells are immature white blood
cells (WBCs) and if their number is proportionately increased,
can suggest infection. In the original SIRS deﬁnition, Bone and
colleagues2 proposed that elevated levels of band cells be
deﬁned as >10% of WBCs.
Blood tests for the relevant variables were taken from the
result closest to admission and additional results included C
reactive protein (CRP) and lymphocyte count. Suspicion of
endocarditis, presence of an indwelling vascular catheter and
the presence of chills or vomiting were obtained from review of
the ED and AMU admission notes independently by two of the
researchers. If there was disagreement, the decision of the
senior researcher was the one taken. As the research team
reviewed the medical notes to ascertain risk factors, it was not
always possible to blind the result of the BC; however, the team
aimed to limit their notes review to the admission clerking to
minimise the introduction of bias. Blood result variables for the
CPR were collected automatically in a blinded fashion;
however, again by reviewing the medical notes, blinding of the
results to the researchers was not always possible.
Statistics
Predictive performance was assessed by discrimination (using
receiver operating characteristic (ROC) curve analysis) and cali-
bration (using the Hosmer–Lemeshow (HL) test). An area under
the ROC curve (AUC) of 0.5 indicates no discrimination,
whereas an AUC of 1.0 indicates perfect discrimination.29 A sig-
niﬁcant HL test statistic (p value <0.05) implies that the model
does not calibrate perfectly, and is, therefore, suspect, though
this does have limitations.32
There is no consensus on how to determine what counts as
an adequate sample size in such studies;29 however, a minimum
of 100 events is generally accepted as adequate sample size
when validating a CPR.33 Due to resource constraints, it was
not possible to review the notes of all negative BCs, and hence,
a random sample of 100 was taken—a nested case–control
design, which has been shown to have advantages in prediction
research.34 Four of the bacteraemic patients notes were unavail-
able for analysis, and were excluded. The remaining 100
patients in each group underwent a complete case analysis. The
only potential missing data were in the history elicited on the
medical clerking—for example, some patients may not have
volunteered or been asked speciﬁcally about vomiting.
Following collection, the data were anonymised on Excel, and
analysis performed on SPSS V.22 (Chicago Q11, Illinois, USA).
RESULTS
From a total of 635 BCs, 104 (17%) were judged to represent
true bacteraemia, compared with 8.3% in the original derivation
study.27 Table 2 summarises the patient characteristics (n=100
bacteraemic, n=100 sterile BC) included in the full analysis.
Figure 1 depicts the frequency of organisms cultured, with
Escherichia coli, Staphylococcus and Streptococcus species
Table 1 Shapiro et al’s clinical prediction rule—a blood culture is
indicated if at least one major criterion or two minor criteria are
present, that is, ≥2 pts
Major criteria* Minor criteria (1 point each)
Suspected endocarditis (3)
Temperature >39.4°C (3)
Indwelling vascular catheter (2)
Temperature 38.3°C–39.4°C
Age >65
Chills
Vomiting
Hypotension—SBP <90 mm Hg
White blood cell >18×109/L
Platelets <150×109/L
Neutrophil ratio >80%
Creatinine >2.0 mg/dL (>177 μmol/L)
Bands >5% (immature white blood cells) were not included as part of the present
analysis as bandaemia is not routinely reported at the study site.
*() indicates the points score.
SBP, systolic BP.
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accounting for over half the cultures. Males accounted for 58%
of both groups (compared with 45% of patients in the Shapiro
derivation cohort27) with a mean age of 68 (SD 15) in the bac-
teraemic and 63 (17) in the sterile-BC group, respectively
(p=0.01). Mean age in the Shapiro study was 60 (20). Length
of stay averaged 13 (17) days in the bacteraemic cohort, and 10
(14) days in the sterile-BC group (p=0.66). In-hospital mortal-
ity rate was 11% in the bacteraemic group and 6% in the
sterile-BC group (p=0.15). SIRS criteria (≥2) was met in 51%
of the bacteraemic group and 37% of the sterile-BC group
(p=0.03).
To predict bacteraemia, the Shapiro criteria,27 at a cut-off of
two points, had 97% (95% CIs 91% to 99%) sensitivity, 37%
speciﬁcity (28% to 47%), positive predictive value 61% (53%
to 68%), negative predictive value (NPV) 93% (80% to 98%),
positive likelihood ratio 1.54 (1.3 to 1.8) and a negative likeli-
hood ratio of 0.08 (0.03 to 0.25). AUC was 0.80 (0.74 to 0.86)
(see ﬁgure 2)—similar to that found in Shapiro’s derivation
(0.80) and validation (0.75) groups and the recently published
external validation study (0.83).28 The Hosmer–Lemeshow
p value was 0.45.
DISCUSSION
This study provides further external validation of the CPR pro-
posed by Shapiro et al27 uniquely in an acute medical UK
cohort, with similar results to the original study and other exter-
nal validation study.28 The initial CPR was proposed to reduce
routine (potentially inappropriate) ordering of BCs and also
highlighted a group at high risk of bacteraemia. Using plausible
clinical history, observations and blood tests, the CPR estimates
the probability of bacteraemia at the point at which a clinician
has decided to draw a BC, identifying a group at low risk of bac-
teraemia (score <2 points).
Limitations
The limited sample size in a single unit should be considered
when drawing comparisons with the Shapiro study (3901 sub-
jects).27 Patients were on average older than the original study,
Table 2 Patient characteristics
Bacteraemia (n=100)
Blood culture
sterile (n=100) p Value
Original Shapiro
derivation cohort
Demographics
Age (mean (SD)) 68.4 (15.4) 62.8 (17.2) 0.01* 59.9 (20.2)
Male sex (%) 58 58 0.58 45
Characteristics
In-hospital mortality (%) 11 6.0 0.15
Length of stay (mean (SD)) (days) 13.4 (16.7) 9.9 (13.8) 0.66
ICU admissions (%) 7 4 0.27
Shapiro criteria
Suspected endocarditis (%) 6 0 0.01* 2
Indwelling vascular catheter (%) 4 3 0.5
Temperature >39.4°C (%) 17 5 <0.01*
Temperature 38.3°C–39.4°C (%) 31 24 0.17
Hypotension (SBP <90 mm Hg) (%) 13 3 <0.01*
Age >65 (%) 64 49 0.023*
Chills (%) 40 9 <0.01*
Vomiting (%) 37 25 0.05*
White blood cell count >18×109/L (%) 27 14 0.02*
Platelets <150×109/L (%) 20 15 0.23
Creatinine >2.0 mg/dL (>177 μmol/L) (%) 14 6 0.05*
Shapiro score
0 1 15
1 2 22
2 15 24
3 26 25
4 19 6
≥5 37 8
Other results
Lactate (mean (SD)) 2.58 (2.7) 2.0 (1.6) 0.27
SIRS ≥2 (%) 51 37 0.03*
Comorbidities
On steroids (%) 17 10 0.10
Immunosuppressed 31 17 0.02*
Cancer 28 22 0.21 19
Diabetes 24 12 0.02* 22
CKD 28 21 0.16
Recent chemotherapy 11 9 0.41
Student’s t test or χ2 test.
*p Value <0.05.
CKD, chronic kidney disease; ICU, intensive care unit; SBP, systolic BP; SIRS, systemic inflammatory response syndrome.
Hodgson LE, et al. Emerg Med J 2015;0:1–8. doi:10.1136/emermed-2015-204926 3
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but representative of a typical general medical hospital setting in
the UK. The external validation study in an ED in Denmark had
a similar age demographic (mean age 71 in the bacteraemia and
63 in the non-bacteraemia groups) and produced statistically
similar results (see table 3).
Though the data were prospectively gathered by clinical
teams as part of routine practice, the retrospective nature of the
analysis is a limitation, whereby bias could be introduced, for
example, by omission of relevant history within the medical
clerking. Local guidelines for taking BCs are available; however,
clinical staff may not have adhered to them. Due to resource
limitations (for the retrospective notes review), only a sample
(100) of the (531) sterile BC episodes were compared with the
bacteraemia episodes, and four of the bacteraemia patients were
excluded from analysis due to unavailable notes. However, the
sample of sterile BCs was comparable with the full dataset of
sterile BCs in the parameters available, with no statistically sig-
niﬁcant differences between the sampled group and those not
sampled (see online supplementary appendix 2 and table S4).
Second, although case–control studies have been shown to be
associated with a risk of bias,35 by randomly selecting from a
known number of negative BC cases, the design is a nested
case–control. In a nested case–control, cases emerge from a
well-deﬁned source population, and the controls are sampled
from that same population. Biesheuvel and colleagues have pre-
viously discussed some of the potential advantages of such a
design in prediction research.34 The nested case Q12–control was an
efﬁcient use of limited resources, but we acknowledge that it
does introduce the potential risk of bias. Jessen and colleagues
also used a similar study design in their validation study.28
Bandaemia was not included in the study as this is not rou-
tinely reported in our Trust. One study previously reported the
presence of bandaemia in 80% of bacteraemia cases; however,
the already high sensitivity would be unlikely to be altered, and
potentially, speciﬁcity may have reduced further by the inclusion
of this variable.36
Implications for future research and practice
A systematic review evaluating decision support systems found
independent predictors of improved clinical practice, including
automatic provision as part of clinician workﬂow, support at the
time and location of decision making and computer-based deci-
sion support.37 This highlights one potential drawback of the
current CPR: the relatively subjective criteria (suspicion of endo-
carditis and chills) limits the ability to automate into an elec-
tronic patient record. Second, the use of 13 predictors may limit
widespread uptake as a decision aid.38 39 Bandaemia is not rou-
tinely reported in most hospitals, making its inclusion question-
able. Using white cell count (WCC), bandaemia and neutrophil
ratio >80% could be considered problematic as they are not
independent.40 In the presented study, 17% of BCs were judged
to be cases of true bacteraemia, compared with only 8% in the
original derivation study and 6.9% in the Danish validation
study. This may reﬂect different practice in the threshold to take
a BC between the UK and the USA or the temporal differences
between the studies. Despite the higher prevalence of bacter-
aemia, an AUC of 0.80 still suggests it is possible to discriminate
those at lower risk of bacteraemia using the CPR, and calibra-
tion was not found to be inadequate using the HL test.
In the studied cohort, on the basis of likelihood ratios (see
online supplementary appendix 3) and attempting to reduce
overlapping, removing 7 of the 12 studied variables and intro-
ducing two other variables (lymphopenia and elevated CRP) did
not lead to a signiﬁcant deterioration in sensitivity or NPV
while increasing speciﬁcity and the AUC (see table 3 and online
supplementary appendix 3, tables S5, S6 and figure S3).
Although age >65 was signiﬁcantly different, and temperature
38.3°C–39.4°C was not, the former was not included to minim-
ise variables, and excluding the elevated temperature would
have resulted in an increase in false negatives, scoring <2. The
literature has consistently demonstrated absolute WCC, as a dis-
criminator, is inferior to lymphocyte count (or neutrophil:
lymphocyte ratio) and CRP.41–46 This more parsimonious model
with seven variables (compared with the Shapiro derivation/
validation studies in table 3) could be further explored and
validated in the future.
An impact analysis study after implementing such a model as
the Shapiro criteria27 should be considered to see whether its
Figure 1 OrganismsQ5 cultured in the cohort (n=100). CNS,
coagulase-negative Staphylococcus species; E. coli, Escherichia coli.
Figure 2 AreaQ14 under the receiver operator curve for the Shapiro
criteria to predict bacteraemia—0.80 (95% CI 0.74 to 0.86).
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employment provides clinical beneﬁt. The Shapiro criteria has
relatively low speciﬁcity for predicting bacteraemia; however,
this may not be unacceptable clinically as it is well known that a
proportion of patients with severe infection, including those
with septic shock, are never proven to be bacteraemic, particu-
larly if antibiotics have already been given, culture sample size is
inadequate or the organism is fastidious. Knowing who is at
very low risk of bacteraemia could be beneﬁcial by reducing
unnecessary BCs. However, another equally important challenge
for clinicians wishing to develop a prediction model in this ﬁeld
would be to accurately risk stratify patients admitted with ‘sus-
pected infection’ into high-risk or lower-risk groups (such as
risk of mortality or requirement for ICU) that could ensure
optimal early treatment and appropriately intensive monitoring.
This study presents further external validation of a prediction
rule identifying with high sensitivity the patients who will be
bacteraemic from a cohort of patients whose clinical team felt
BCs were indicated to investigate for possible bacteraemia.
Perhaps, the major implication of the Shapiro criteria rule is
that with a low score (<2), a patient is at low risk of bacter-
aemia, and this could safely allow a signiﬁcant reduction in the
number of cultures performed with the subsequent advantage of
reducing contaminant results. The large number of variables
and difﬁculty in automating the model are the shortcomings
that could be addressed by exploring the modiﬁed Worthing–
Shapiro model.
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